Literature DB >> 2019282

Abnormal bone marrow distribution following unsuccessful hip replacement: a potential confusion on white cell scanning.

D A Cunningham1.   

Abstract

A case is presented in which a grossly abnormal distribution of bone marrow following failed hip replacement would have led to the false diagnosis of osteomyelitis. The value of combining bone marrow scanning with indium white cell scanning in possible osteomyelitis is emphasised.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2019282     DOI： 10.1007/bf00177685

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


  5 in total

1.  Autologous granulocyte scanning of painful prosthetic joints.

Authors:  D J Pring; R G Henderson; A G Rivett; T Krausz; R R Coombs; J P Lavender
Journal:  J Bone Joint Surg Br       Date:  1986-08

2.  99Tcm-labelled HSA-nanocolloid versus 111In oxine-labelled granulocytes in detecting skeletal septic process.

Authors:  K Streule; M de Schrijver; R Fridrich
Journal:  Nucl Med Commun       Date:  1988-01       Impact factor: 1.690

3.  Indium-111 leucocyte scanning in the evaluation of painful hip arthroplasty.

Authors:  L Mulamba; A Ferrant; N Leners; P de Nayer; J J Rombouts; A Vincent
Journal:  Acta Orthop Scand       Date:  1983-10

4.  Imaging of inflammation with indium-111 tropolonate labeled leukocytes.

Authors:  A M Peters; S H Saverymuttu; H J Reavy; H J Danpure; S Osman; J P Lavender
Journal:  J Nucl Med       Date:  1983-01       Impact factor: 10.057

5.  In-111-labeled leukocyte scintigraphy in suspected orthopedic prosthesis infection: comparison with other imaging modalities.

Authors:  J E Magnuson; M L Brown; M F Hauser; T H Berquist; R H Fitzgerald; G G Klee
Journal:  Radiology       Date:  1988-07       Impact factor: 11.105
  5 in total
  1 in total

1.  The value of Tc-99m Nanocolloid scintigraphy in the evaluation of infected total hip arthroplasties.

Authors:  I Bernay; M Akinci; M Kitapçi; N Tokgözoglu; G Erbengi
Journal:  Ann Nucl Med       Date:  1993-11       Impact factor: 2.668
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.